局部晚期宫颈癌腹主动脉旁分期术中腹腔镜盆腔肿大淋巴结减灭术的回顾性比较队列研究
本研究为西班牙11家医院的多中心回顾性比较队列研究,纳入381例局部晚期宫颈癌(FIGO 2018 IIIC1r及以上)接受同步放化疗前分期的患者。比较盆腔淋巴结减灭+腹主动脉旁淋巴结清扫(组1)、仅腹主动脉旁淋巴结清扫(组2)及未行淋巴结手术分期(组3)的预后与并发症。结果显示三组无病生存和总生存相似(p=.95),组1与组2手术并发症无差异,淋巴结减灭可确认转移并指导放疗 boost,避免阴性患者过度治疗。
要点
- 盆腔淋巴结减灭未影响无病生存和总生存(p=.95)。
- 组1与组2术中、早期及晚期术后并发症均无差异。
- 组1A放疗相关早期和晚期并发症少于其他组(p=.022)。
核心结论
- 局部晚期宫颈癌影像可疑淋巴结患者行腹主动脉旁分期术中腹腔镜盆腔淋巴结减灭,可确认转移淋巴结而不影响生存或增加手术并发症。
研究设计与样本
- 西班牙11家妇科肿瘤专科医院开展的多中心回顾性比较队列研究,共纳入381例局部晚期宫颈癌(FIGO 2018 IIIC1r及以上)接受同步放化疗前分期的患者。
主要发现
- 组1盆腔淋巴结受累率为43.3%(71/164),腹主动脉旁受累率为24.4%(40/164)。
- 组2腹主动脉旁淋巴结阳性率为29.7%(33/111)。
- 三组无病生存和总生存相似(p=.95),组1A与组1B间亦相似(p=.25)。
- 组1与组2术中(3.7% vs 2.7%,p=.744)、早期术后(8.0% vs 6.3%,p=.776)及晚期术后并发症(6.1% vs 2.7%,p=.252)均无差异。
- 组1A放疗相关早期和晚期并发症少于其他组(p=.022)。
临床怎么用
- 对影像学可疑淋巴结的局部晚期宫颈癌患者,在腹主动脉旁分期术中行腹腔镜盆腔淋巴结减灭可明确淋巴结转移状态,指导 boost 照射选择并避免阴性患者过度治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To evaluate laparoscopic pelvic lymph node debulking during extraperitoneal aortic lymphadenectomy in diagnosis, therapeutic planning, and prognosis of patients with locally advanced cervical cancer and enlarged lymph nodes on imaging before chemoradiotherapy. DESIGN: Retrospective, multicenter, comparative cohort study. SETTING: The study was carried out at 11 hospitals with specialized gynecologic oncology units in Spain. PATIENTS: Total of 381 women with locally advanced cervical cancer and International Federation of Gynecology and Obstetrics 2018 stage IIIC 1r (radiologic) and higher who received primary treatment with chemoradiotherapy. INTERVENTIONS: Patients underwent pelvic lymph node debulking and para-aortic lymphadenectomy (group 1), only para-aortic lymphadenectomy (group 2), or no lymph node surgical staging (group 3). On the basis of pelvic node histology, group 1 was subdivided as negative (group 1A) or positive (group 1B). MEASUREMENTS AND MAIN RESULTS: False positives and negatives of imaging tests, disease-free survival, overall survival, and postoperative complications were evaluated. In group 1, pelvic lymph node involvement was 43.3% (71 of 164), and aortic involvement was 24.4% (40 of 164). In group 2, aortic nodes were positive in 29.7% (33 of 111). Disease-free survival and overall survival were similar in the 3 groups (p = .95) and in groups 1A and 1B (p = .25). No differences were found between groups 1 and 2 in intraoperative (3.7% vs 2.7%, p = .744), early postoperative (8.0% vs 6.3%, p = .776), or late postoperative complications (6.1% vs 2.7%, p = .252). Fewer early and late complications were attributed to radiotherapy in group 1A than in the others (p = .022). CONCLUSION: Laparoscopic pelvic lymph node debulking during para-aortic staging surgery in patients with locally advanced cervical cancer with suspicious nodes allows for the confirmation of metastatic lymph nodes without affecting survival or increasing surgical complications. This information improves the selection of patients requiring boost irradiation, thus avoiding overtreatment of patients with negative nodes.
引用
- Díaz-Feijoo B, Acosta Ú, Torné A, et al. Laparoscopic Debulking of Enlarged Pelvic Nodes during Surgical Para-aortic Staging in Locally Advanced Cervical Cancer: A Retrospective Comparative Cohort Study. J Minim Invasive Gynecol. 2021. PMID: 34217852. doi:10.1016/j.jmig.2021.06.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。